- Previous Close
103.24 - Open
102.75 - Bid 103.92 x 800
- Ask 103.96 x 800
- Day's Range
102.75 - 103.96 - 52 Week Range
75.08 - 115.50 - Volume
342,355 - Avg. Volume
2,087,274 - Market Cap (intraday)
57.7B - Beta (5Y Monthly) 0.96
- PE Ratio (TTM)
15.43 - EPS (TTM)
6.73 - Earnings Date Jan 29, 2025 - Feb 3, 2025
- Forward Dividend & Yield 2.32 (2.26%)
- Ex-Dividend Date Feb 19, 2025
- 1y Target Est
105.77
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
www.aflac.com12,785
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AFL
View MorePerformance Overview: AFL
Trailing total returns as of 12/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AFL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AFL
View MoreValuation Measures
Market Cap
57.35B
Enterprise Value
63.95B
Trailing P/E
15.34
Forward P/E
14.39
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.39
Price/Book (mrq)
2.31
Enterprise Value/Revenue
3.67
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
22.01%
Return on Assets (ttm)
2.35%
Return on Equity (ttm)
16.04%
Revenue (ttm)
17.3B
Net Income Avi to Common (ttm)
3.81B
Diluted EPS (ttm)
6.73
Balance Sheet and Cash Flow
Total Cash (mrq)
9.16B
Total Debt/Equity (mrq)
50.14%
Levered Free Cash Flow (ttm)
2.89B